1. Home
  2. ACHV vs VWAV Comparison

ACHV vs VWAV Comparison

Compare ACHV & VWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.59

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

VWAV

VisionWave Holdings Inc.

HOLD

Current Price

$5.09

Market Cap

139.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
VWAV
Founded
N/A
2024
Country
United States
United States
Employees
N/A
12
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
172.0M
139.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ACHV
VWAV
Price
$4.59
$5.09
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$14.67
N/A
AVG Volume (30 Days)
1.2M
474.6K
Earning Date
05-11-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$2.06
52 Week High
$6.15
$15.80

Technical Indicators

Market Signals
Indicator
ACHV
VWAV
Relative Strength Index (RSI) 48.02 41.61
Support Level $4.09 $4.72
Resistance Level $4.98 $6.49
Average True Range (ATR) 0.40 0.42
MACD -0.12 -0.03
Stochastic Oscillator 7.56 15.60

Price Performance

Historical Comparison
ACHV
VWAV

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About VWAV VisionWave Holdings Inc.

VisionWave Holdings Inc is a technology company focused on the development and commercialization of artificial intelligence (AI) and autonomous solutions across air, ground and sea environments. Through its subsidiary, the Company designs and deploys technologies including radars, radio frequency (RF) sensing, unmanned aerial and ground systems, remote weapon stations and active protection systems for defense, military, homeland security and industrial applications. Its proprietary AI engine supports autonomous decision-making and product lines at various stages of development and commercialization. Revenue is generated through product sales, technology licensing, strategic alliances and joint ventures, with products including C-UAS, multi-purpose autonomous UAS and Vision-AI technology.

Share on Social Networks: